CAPRICOR THERAPEUTICS, INC. Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Research and Development Arrangement, Contract to Perform for Others, Compensation Earned of $1.55 million for the 13-month period ending 2012-02-29, per its 10-K filed 2014-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned · last filed 2014-03-31
- 2012-02-29: Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 1 month $195.50K; Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 13 month $1.55M.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 1 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 13 month |
|---|---|---|
| 2012-02-29 | $195.50K 10-K · filed 2014-03-31 | $1.55M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |